The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks.
Publication
, Journal Article
Hung, A; Sieluk, J; Doshi, P
Published in: JAMA Intern Med
January 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
January 2016
Volume
176
Issue
1
Start / End Page
11 / 12
Location
United States
Related Subject Headings
- Risk Assessment
- Pharmacies
- Pharmaceutical Services
- Pharmaceutical Preparations
- Patient Education as Topic
- Pamphlets
- Humans
- Drug-Related Side Effects and Adverse Reactions
- 4203 Health services and systems
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hung, A., Sieluk, J., & Doshi, P. (2016). The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks. JAMA Intern Med, 176(1), 11–12. https://doi.org/10.1001/jamainternmed.2015.6656
Hung, Anna, Jan Sieluk, and Peter Doshi. “The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks.” JAMA Intern Med 176, no. 1 (January 2016): 11–12. https://doi.org/10.1001/jamainternmed.2015.6656.
Hung A, Sieluk J, Doshi P. The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks. JAMA Intern Med. 2016 Jan;176(1):11–2.
Hung, Anna, et al. “The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks.” JAMA Intern Med, vol. 176, no. 1, Jan. 2016, pp. 11–12. Pubmed, doi:10.1001/jamainternmed.2015.6656.
Hung A, Sieluk J, Doshi P. The Untapped Potential of Pharmacy Leaflets for Informing Patients About Drug Benefits and Risks. JAMA Intern Med. 2016 Jan;176(1):11–12.
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
January 2016
Volume
176
Issue
1
Start / End Page
11 / 12
Location
United States
Related Subject Headings
- Risk Assessment
- Pharmacies
- Pharmaceutical Services
- Pharmaceutical Preparations
- Patient Education as Topic
- Pamphlets
- Humans
- Drug-Related Side Effects and Adverse Reactions
- 4203 Health services and systems
- 3202 Clinical sciences